Author: Chanaka N Kahathuduwa; Chathurika S Dhanasekara; Shao-Hua Chin
Title: Case fatality rate in COVID-19: a systematic review and meta-analysis Document date: 2020_4_6
ID: dcf6bl8f_16
Snippet: Heterogeneity of effect-sizes on prevalence of mortality in COVID-19 was also a concern 222 (Ï„ 2 = 2.996; I 2 = 86%, p < 0.001). Correction for publication bias decreased the heterogeneity (I 2 223 = 61%, 95%CI, 45%-73%), yet the heterogeneity remained significant (p < 0.001). Univariate 224 meta-regression analyses modeling heterogeneity indicated increased mortality risks associated 225 with increasing mean age (p < 0.001), prevalence of age >.....
Document: Heterogeneity of effect-sizes on prevalence of mortality in COVID-19 was also a concern 222 (Ï„ 2 = 2.996; I 2 = 86%, p < 0.001). Correction for publication bias decreased the heterogeneity (I 2 223 = 61%, 95%CI, 45%-73%), yet the heterogeneity remained significant (p < 0.001). Univariate 224 meta-regression analyses modeling heterogeneity indicated increased mortality risks associated 225 with increasing mean age (p < 0.001), prevalence of age > 60 years (p = 0.011), presenting with 226 fatigue (p = 0.048), leukocytosis (p =0.007), high LDH (p = 0.030) and low albumin (p < 0.001).
Search related documents:
Co phrase search for related documents- age prevalence and increase mortality risk: 1, 2
- age prevalence and mean age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56
- age prevalence and meta regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- age prevalence and mortality prevalence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- age prevalence and mortality risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
- age prevalence and publication bias: 1, 2
- effect size and increase mortality risk: 1
- effect size and low albumin: 1
- effect size and mean age: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48
- effect size and meta regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- effect size and model heterogeneity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- effect size and mortality prevalence: 1
- effect size and mortality risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
- effect size and publication bias: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60
- effect size heterogeneity and meta regression: 1, 2
- effect size heterogeneity and model heterogeneity: 1, 2
- effect size heterogeneity and publication bias: 1, 2, 3, 4, 5, 6, 7, 8
- increase mean age and mean age: 1, 2, 3, 4, 5, 6, 7, 8, 9
- increase mean age and meta regression: 1
Co phrase search for related documents, hyperlinks ordered by date